{
    "hands_on_practices": [
        {
            "introduction": "The clinical utility of a diagnostic test, such as the Test of Memory Malingering (TOMM), is not an inherent property of the test itself, but rather a function of its interaction with the population in which it is used. This exercise demonstrates how a test's predictive power changes dramatically with the base rate of the condition being assessed. By deriving Positive and Negative Predictive Values (PPV and NPV) from first principles, you will gain a deeper, more flexible understanding of how to interpret test results in real-world settings with varying prevalences of malingering .",
            "id": "4711860",
            "problem": "In a forensic psychiatric assessment, the Test of Memory Malingering (TOMM) is used to evaluate the likelihood of feigned cognitive impairment. Suppose the TOMM uses a specific cutoff that yields sensitivity $0.90$ and specificity $0.95$ in the target population. In a given clinical-legal setting, the base rate (prevalence) of malingering among those evaluated is estimated to be $0.20$. Using only the core definitions of sensitivity, specificity, prevalence, the law of total probability, and Bayes’ theorem, proceed as follows:\n\n1. Define events and derive from first principles symbolic expressions for the positive predictive value (PPV) and negative predictive value (NPV) of this TOMM cutoff as functions of prevalence $p$, sensitivity $s$, and specificity $c$.\n\n2. Evaluate your expressions at $s=0.90$, $c=0.95$, and $p=0.20$ to obtain numerical values for $PPV$ and $NPV$. Round your numerical results to four significant figures. Express the final numbers as decimals.\n\n3. Briefly, using your symbolic expressions (not additional numerical computation), explain qualitatively how shifts in prevalence $p$ impact $PPV$ and $NPV$, and relate this to interpretive confidence in positive versus negative TOMM findings when the base rate of malingering changes.\n\nReport your final numerical answer as a row matrix with two entries in the order $[PPV, NPV]$. No additional text or units should appear in the final numerical answer.",
            "solution": "The problem as stated is scientifically grounded, well-posed, and objective. It presents a standard application of Bayesian probability theory to evaluate the performance of a diagnostic test, using realistic parameters for the clinical context described. The problem provides all necessary data and constraints to derive a unique, meaningful solution. Therefore, a problem is deemed valid.\n\nThe solution proceeds in three parts as requested: derivation of symbolic expressions, numerical evaluation, and qualitative analysis.\n\n**1. Derivation of Symbolic Expressions for PPV and NPV**\n\nFirst, we define the relevant events and translate the given parameters into probabilistic terms.\nLet $M$ be the event that an individual is malingering (the \"condition\" is present).\nLet $M^c$ be the complementary event that an individual is not malingering.\nLet $T^+$ be the event that the test result is positive.\nLet $T^-$ be the event that the test result is negative.\n\nThe problem provides the following quantities:\n- Prevalence, $p$: The prior probability of malingering.\n  $$p = P(M) = 0.20$$\n  The probability of not malingering is therefore $P(M^c) = 1 - P(M) = 1-p$.\n\n- Sensitivity, $s$: The probability of a positive test result given that the individual is malingering. This is the true positive rate.\n  $$s = P(T^+ | M) = 0.90$$\n\n- Specificity, $c$: The probability of a negative test result given that the individual is not malingering. This is the true negative rate.\n  $$c = P(T^- | M^c) = 0.95$$\n\nFrom these definitions, we can derive the probabilities of the complementary conditional events:\n- The false negative rate, the probability of a negative test given malingering, is:\n  $$P(T^- | M) = 1 - P(T^+ | M) = 1-s$$\n- The false positive rate, the probability of a positive test given no malingering, is:\n  $$P(T^+ | M^c) = 1 - P(T^- | M^c) = 1-c$$\n\n**Positive Predictive Value (PPV)**\nThe positive predictive value, $PPV$, is the post-test probability that an individual is malingering given a positive test result. This is the conditional probability $P(M | T^+)$. We use Bayes' theorem to derive its expression:\n$$PPV = P(M | T^+) = \\frac{P(T^+ | M) P(M)}{P(T^+)}$$\nTo find the denominator, $P(T^+)$, we apply the law of total probability, which marginalizes over the state of malingering:\n$$P(T^+) = P(T^+ | M)P(M) + P(T^+ | M^c)P(M^c)$$\nSubstituting our symbolic definitions into this expression gives:\n$$P(T^+) = (s)(p) + (1-c)(1-p)$$\nNow, substituting this back into the expression for $PPV$:\n$$PPV = \\frac{s \\cdot p}{s \\cdot p + (1-c)(1-p)}$$\nThis is the symbolic expression for $PPV$ as a function of $p$, $s$, and $c$.\n\n**Negative Predictive Value (NPV)**\nThe negative predictive value, $NPV$, is the post-test probability that an individual is not malingering given a negative test result. This is the conditional probability $P(M^c | T^-)$. Again, we use Bayes' theorem:\n$$NPV = P(M^c | T^-) = \\frac{P(T^- | M^c) P(M^c)}{P(T^-)}$$\nThe denominator, $P(T^-)$, is found using the law of total probability:\n$$P(T^-) = P(T^- | M^c)P(M^c) + P(T^- | M)P(M)$$\nSubstituting our symbolic definitions:\n$$P(T^-) = (c)(1-p) + (1-s)(p)$$\nSubstituting this back into the expression for $NPV$:\n$$NPV = \\frac{c(1-p)}{c(1-p) + (1-s)p}$$\nThis is the symbolic expression for $NPV$ as a function of $p$, $s$, and $c$.\n\n**2. Numerical Evaluation**\n\nWe are given $s=0.90$, $c=0.95$, and $p=0.20$. We also compute the complementary values: $1-s = 0.10$, $1-c = 0.05$, and $1-p = 0.80$.\n\n**Evaluation of PPV:**\n$$PPV = \\frac{(0.90)(0.20)}{(0.90)(0.20) + (1-0.95)(1-0.20)} = \\frac{0.18}{0.18 + (0.05)(0.80)}$$\n$$PPV = \\frac{0.18}{0.18 + 0.04} = \\frac{0.18}{0.22} = \\frac{9}{11}$$\nAs a decimal rounded to four significant figures, this is:\n$$PPV \\approx 0.8182$$\n\n**Evaluation of NPV:**\n$$NPV = \\frac{(0.95)(1-0.20)}{(0.95)(1-0.20) + (1-0.90)(0.20)} = \\frac{(0.95)(0.80)}{(0.95)(0.80) + (0.10)(0.20)}$$\n$$NPV = \\frac{0.76}{0.76 + 0.02} = \\frac{0.76}{0.78} = \\frac{38}{39}$$\nAs a decimal rounded to four significant figures, this is:\n$$NPV \\approx 0.9744$$\n\n**3. Qualitative Analysis of the Impact of Prevalence**\n\nThe derived symbolic expressions allow for a qualitative analysis of how $PPV$ and $NPV$ change with prevalence $p$, holding sensitivity $s$ and specificity $c$ constant.\n\n**Impact on PPV:**\nThe expression for $PPV$ is $PPV = \\frac{s \\cdot p}{s \\cdot p + (1-c)(1-p)}$. To analyze its dependence on $p$, we can consider the partial derivative $\\frac{\\partial (PPV)}{\\partial p}$. Using the quotient rule:\n$$\\frac{\\partial (PPV)}{\\partial p} = \\frac{s(sp + (1-c)(1-p)) - sp(s - (1-c))}{(sp + (1-c)(1-p))^2}$$\n$$\\frac{\\partial (PPV)}{\\partial p} = \\frac{s^2p + s(1-c)(1-p) - s^2p + sp(1-c)}{(sp + (1-c)(1-p))^2}$$\n$$\\frac{\\partial (PPV)}{\\partial p} = \\frac{s(1-c)(1-p) + sp(1-c)}{(sp + (1-c)(1-p))^2} = \\frac{s(1-c)[(1-p)+p]}{(sp + (1-c)(1-p))^2} = \\frac{s(1-c)}{(sp + (1-c)(1-p))^2}$$\nSince $s$ and $c$ are probabilities between $0$ and $1$, $s > 0$ and $1-c > 0$. The denominator is a squared term and thus positive. Therefore, $\\frac{\\partial (PPV)}{\\partial p} > 0$. This demonstrates that $PPV$ is a monotonically increasing function of prevalence $p$.\nQualitatively, as the base rate of malingering increases in a population, the probability that a positive test result is a true positive also increases. Thus, our confidence in a positive finding is higher in high-prevalence settings.\n\n**Impact on NPV:**\nThe expression for $NPV$ is $NPV = \\frac{c(1-p)}{c(1-p) + (1-s)p}$. We analyze its dependence on $p$ by finding $\\frac{\\partial (NPV)}{\\partial p}$:\n$$\\frac{\\partial (NPV)}{\\partial p} = \\frac{-c(c(1-p) + (1-s)p) - c(1-p)(-c + (1-s))}{(c(1-p) + (1-s)p)^2}$$\n$$\\frac{\\partial (NPV)}{\\partial p} = \\frac{-c^2(1-p) - c(1-s)p + c^2(1-p) - c(1-p)(1-s)}{(c(1-p) + (1-s)p)^2}$$\n$$\\frac{\\partial (NPV)}{\\partial p} = \\frac{-c(1-s)p - c(1-s)(1-p)}{(c(1-p) + (1-s)p)^2} = \\frac{-c(1-s)[p + (1-p)]}{(c(1-p) + (1-s)p)^2} = \\frac{-c(1-s)}{(c(1-p) + (1-s)p)^2}$$\nSince $c > 0$ and $1-s > 0$, the numerator is negative. The denominator is positive. Therefore, $\\frac{\\partial (NPV)}{\\partial p}  0$. This demonstrates that $NPV$ is a monotonically decreasing function of prevalence $p$.\nQualitatively, as the base rate of malingering increases, the probability that a negative test result corresponds to a truly non-malingering individual decreases. This is because with more malingerers in the population, there is a greater absolute number of false negatives, which diminishes the \"value\" of a negative test. Our confidence in a negative finding is highest in low-prevalence settings and erodes as the base rate rises.",
            "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.8182  0.9744\n\\end{pmatrix}\n}\n$$"
        },
        {
            "introduction": "Distinguishing factitious disorder from an organic medical condition often hinges on the skillful integration of biochemical evidence with psychosocial data. This is especially true in cases of mysterious hypoglycemia, where the source of insulin becomes the central diagnostic question. This hands-on practice guides you through a classic clinical vignette, requiring the application of basic endocrine physiology—specifically the relationship between insulin and C-peptide—to uncover deception and then use the patient's history to differentiate the underlying motive .",
            "id": "4711829",
            "problem": "A $32$-year-old medical assistant with no known history of diabetes mellitus presents with recurrent episodes of confusion and diaphoresis. During two separate admissions, plasma glucose values were documented at $38$ mg/dL and $41$ mg/dL, respectively. She reports an intense interest in learning medical procedures and frequently volunteers to stay late in the clinic. She denies any interest in work leave, legal claims, or financial compensation. She lives alone. On interview, she expresses that she “feels most herself” when she is being cared for in the hospital and keeps a personal blog about her medical experiences.\n\nBetween episodes, her hemoglobin A1c (HbA1c) is $5.2\\%$, serum creatinine is $0.8$ mg/dL, and estimated glomerular filtration rate (eGFR) is $110$ mL/min/1.73 m$^2$. A toxicology screen is negative for oral hypoglycemics except for a dedicated high-performance liquid chromatography–mass spectrometry (HPLC–MS) sulfonylurea panel, which is negative. At the time of hypoglycemia, a fasting blood sample is drawn, analyzed on an immunoassay validated to detect commonly used exogenous human insulin analogs, with the following results: serum insulin $42$ µU/mL (reference $3$ µU/mL during hypoglycemia), C-peptide $0.2$ ng/mL, and proinsulin $1.0$ pmol/L. Anti-insulin antibody testing is negative.\n\nStarting from the basic physiology that pancreatic beta cells synthesize proinsulin and cleave it into insulin and connecting peptide in an equimolar ratio, and considering the differential clearance pathways of insulin (primarily hepatic) and C-peptide (primarily renal), which of the following is the most parsimonious explanation for the biochemical pattern and the clinical presentation?\n\nA. Factitious disorder imposed on self with surreptitious exogenous insulin administration\n\nB. Malingering with covert exogenous insulin use to obtain disability benefits\n\nC. Pancreatic beta-cell adenoma (insulinoma) causing endogenous hyperinsulinemic hypoglycemia\n\nD. Surreptitious sulfonylurea ingestion leading to endogenous insulin secretion\n\nE. Autoimmune insulin syndrome due to anti-insulin antibodies",
            "solution": "The problem asks for the most parsimonious explanation for a patient's recurrent hypoglycemia, integrating her clinical presentation, psychosocial history, and detailed biochemical findings. The solution requires a systematic evaluation of the differential diagnosis for hypoglycemia.\n\n**1. Initial Assessment: Characterizing the Hypoglycemia**\n\nThe patient presents with symptoms of neuroglycopenia (confusion) and autonomic activation (diaphoresis) at times of documented low plasma glucose levels ($38$ mg/dL and $41$ mg/dL). This satisfies Whipple's triad (symptoms of hypoglycemia, low blood glucose, and assumed resolution of symptoms with glucose), confirming clinically significant hypoglycemia.\n\nThe next critical step is to determine if the hypoglycemia is insulin-mediated. During a hypoglycemic state in a healthy individual, the pancreatic beta-cells should cease insulin secretion. The reference value provided, serum insulin $3$ µU/mL during hypoglycemia, reflects this physiological suppression. However, the patient's serum insulin level was measured at $42$ µU/mL. This inappropriately high insulin level in the face of hypoglycemia confirms a diagnosis of **hyperinsulinemic hypoglycemia**.\n\n**2. Differentiating Endogenous vs. Exogenous Hyperinsulinism**\n\nThe core of the problem lies in determining the source of the excess insulin. The provided physiological principle is central to this differentiation: pancreatic beta cells synthesize proinsulin, which is cleaved to release insulin and C-peptide (connecting peptide) in an equimolar ($1:1$) ratio into the circulation.\n\n*   **Endogenous hyperinsulinism**: If the pancreas is the source of the excess insulin (e.g., due to an insulin-secreting tumor (insulinoma) or stimulation by a drug like a sulfonylurea), both insulin and C-peptide will be secreted in excess. This would lead to high levels of both insulin and C-peptide. Proinsulin levels may also be elevated, particularly in insulinomas where processing of proinsulin to insulin can be inefficient.\n\n*   **Exogenous hyperinsulinism**: If insulin is administered from an external source (i.e., injection), commercially available insulin formulations do not contain C-peptide. The high levels of circulating exogenous insulin provide strong negative feedback to the patient's own pancreatic beta-cells, suppressing the entire secretory pathway. This results in suppressed secretion of endogenous insulin, C-peptide, and proinsulin.\n\n**3. Analysis of the Patient's Biochemical Profile**\n\nLet's analyze the patient's laboratory results from the sample drawn during hypoglycemia:\n*   **Serum Insulin**: $42$ µU/mL. This is markedly elevated (reference $3$ µU/mL), confirming hyperinsulinemia. The problem states the assay detects commonly used exogenous insulin analogs, so this value reflects the total circulating insulin.\n*   **C-peptide**: $0.2$ ng/mL. This level is very low, indicating profound suppression of pancreatic beta-cell secretion. In a state of endogenous hyperinsulinemia, C-peptide would be expected to be elevated, typically $0.6$ ng/mL. The patient's normal renal function (eGFR $110$ mL/min/$1.73$ m$^2$) is crucial, as it confirms that this low C-peptide level is not an artifact of increased renal clearance; rather, it is a true reflection of suppressed production.\n*   **Proinsulin**: $1.0$ pmol/L. This level is also low, consistent with pancreatic suppression. In an insulinoma, proinsulin is often disproportionately elevated (e.g., $5$ pmol/L or representing $25\\%$ of total immunoreactive insulin).\n\nThe biochemical triad of **high insulin, low C-peptide, and low proinsulin** is the definitive signature of **exogenous insulin administration**.\n\n**4. Integrating the Clinical and Psychosocial Context**\n\nHaving established exogenous insulin administration as the cause, we must now determine the patient's motivation, which distinguishes between factitious disorder and malingering.\n*   **Malingering** is characterized by the intentional production of symptoms for a recognizable external incentive (e.g., financial gain, avoiding work or legal responsibilities).\n*   **Factitious disorder** is characterized by the intentional production of symptoms driven by an internal need to assume the \"sick role,\" without obvious external rewards.\n\nThe patient's history is highly suggestive of factitious disorder:\n*   She is a medical assistant, providing her with the specialized knowledge and access required to obtain and administer insulin surreptitiously.\n*   She explicitly \"denies any interest in work leave, legal claims, or financial compensation,\" arguing against a motive of external gain (malingering).\n*   Her motivation appears internal and psychological: she \"feels most herself\" when being cared for in the hospital and maintains a blog about her medical experiences, indicating a desire to inhabit the patient role.\n\n**5. Evaluation of Provided Options**\n\n*   **A. Factitious disorder imposed on self with surreptitious exogenous insulin administration**: This diagnosis is consistent with all aspects of the case. The biochemical findings (high insulin, low C-peptide/proinsulin) prove exogenous insulin use. The psychosocial history (medical professional, no external incentive, desire to be in the sick role) is the classic presentation of factitious disorder. This is the most parsimonious explanation.\n    *   Verdict: **Correct**.\n\n*   **B. Malingering with covert exogenous insulin use to obtain disability benefits**: While this option correctly identifies exogenous insulin use, it incorrectly assigns the motivation. The problem statement provides specific information that contradicts the motive of malingering (denial of interest in financial compensation, work leave, etc.).\n    *   Verdict: **Incorrect**.\n\n*   **C. Pancreatic beta-cell adenoma (insulinoma) causing endogenous hyperinsulinemic hypoglycemia**: This would be a cause of endogenous hyperinsulinemia. As derived above, it would present with elevated C-peptide and proinsulin levels, which is the opposite of this patient's findings.\n    *   Verdict: **Incorrect**.\n\n*   **D. Surreptitious sulfonylurea ingestion leading to endogenous insulin secretion**: Sulfonylurea use stimulates the pancreas, causing endogenous hyperinsulinemia, which would lead to elevated C-peptide. This is contrary to the patient's labs. Furthermore, this was specifically ruled out by a negative high-sensitivity HPLC–MS panel.\n    *   Verdict: **Incorrect**.\n\n*   **E. Autoimmune insulin syndrome due to anti-insulin antibodies**: This rare condition can cause hypoglycemia with a high total insulin level and suppressed C-peptide. However, the diagnosis requires the presence of anti-insulin antibodies. The problem states that \"Anti-insulin antibody testing is negative,\" which definitively excludes this diagnosis.\n    *   Verdict: **Incorrect**.\n\nIn conclusion, the combination of biochemical evidence pointing to exogenous insulin administration and psychosocial factors indicating a desire to assume the sick role without external incentives makes factitious disorder imposed on self the only fitting diagnosis.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "In high-stakes diagnostic scenarios, such as differentiating malingering from factitious disorder in a forensic context, the costs of a mistake are rarely symmetrical. A false positive may carry different consequences than a false negative, and a rational decision-maker must weigh these potential harms. This advanced problem introduces Signal Detection Theory (SDT) as a powerful framework to formalize this process, allowing you to calculate an optimal decision threshold that minimizes the total expected cost (or \"Bayes risk\") based on both the probabilities and the asymmetric consequences of error .",
            "id": "4711834",
            "problem": "A forensic psychiatry service evaluates patients suspected of deceptive symptom production using a continuous composite index $X$ derived from performance validity testing and improbable symptom endorsement. Let $H_{1}$ denote \"malingering\" (intentional symptom production motivated by external incentives) and $H_{0}$ denote \"factitious disorder\" (intentional symptom production without external incentives). Assume that, conditional on the true state, the index $X$ has Gaussian class-conditional densities with equal variance. Specifically,\n- under $H_{1}$ (malingering), $X \\sim \\mathcal{N}(\\mu_{1}, \\sigma^{2})$ with $\\mu_{1} = 60$ and $\\sigma = 10$,\n- under $H_{0}$ (factitious disorder), $X \\sim \\mathcal{N}(\\mu_{0}, \\sigma^{2})$ with $\\mu_{0} = 40$ and the same $\\sigma = 10$.\n\nAmong intentionally deceptive referrals to this service, the prior probability of malingering is $\\pi_{1} = 0.65$ and the prior probability of factitious disorder is $\\pi_{0} = 0.35$. Decisions are made by thresholding $X$ at a scalar value $\\tau$: if $X \\ge \\tau$, the clinician classifies as malingering; if $X  \\tau$, the clinician classifies as factitious disorder.\n\nLet the loss (cost) matrix reflect asymmetric harms:\n- true malingering ($H_{1}$) decided as malingering: cost $0$,\n- true malingering ($H_{1}$) decided as factitious disorder (false negative): cost $C_{FN} = 10$,\n- true factitious disorder ($H_{0}$) decided as factitious disorder: cost $0$,\n- true factitious disorder ($H_{0}$) decided as malingering (false positive): cost $C_{FP} = 30$.\n\nUsing Signal Detection Theory (SDT), derive from first principles the decision rule that minimizes the expected loss (Bayes risk) under this cost matrix and these priors, and compute the corresponding optimal scalar threshold $\\tau$ on $X$. Round your final numerical value of $\\tau$ to four significant figures. Express your answer in the score units of $X$.",
            "solution": "The problem requires the derivation of an optimal decision threshold, $\\tau$, for classifying a patient's state as either $H_1$ (malingering) or $H_0$ (factitious disorder) based on a continuous index $X$. The optimality criterion is the minimization of the expected loss, also known as the Bayes risk. The decision rule is to classify as $H_1$ if $X \\ge \\tau$ and as $H_0$ if $X  \\tau$.\n\nLet $D_1$ be the decision to classify the state as $H_1$, and $D_0$ be the decision to classify as $H_0$. The problem provides a loss matrix, which we denote as $C(D_i, H_j)$, representing the cost of making decision $D_i$ when the true state is $H_j$. The given costs are:\n$C(D_1, H_1) = 0$\n$C(D_0, H_1) = C_{FN} = 10$ (False Negative)\n$C(D_0, H_0) = 0$\n$C(D_1, H_0) = C_{FP} = 30$ (False Positive)\n\nThe core of Bayesian decision theory is to make a decision that minimizes the posterior expected loss for a given observation $X=x$. The posterior expected loss for making decision $D_i$ is given by:\n$$\nR(D_i | x) = \\sum_{j=0}^{1} C(D_i, H_j) P(H_j | x)\n$$\nwhere $P(H_j|x)$ is the posterior probability of state $H_j$ given the observation $x$.\n\nLet's calculate the posterior expected loss for each of the two possible decisions, $D_1$ and $D_0$:\nFor decision $D_1$ (classify as malingering):\n$$\nR(D_1 | x) = C(D_1, H_1) P(H_1 | x) + C(D_1, H_0) P(H_0 | x) = 0 \\cdot P(H_1 | x) + C_{FP} \\cdot P(H_0 | x) = C_{FP} P(H_0 | x)\n$$\nFor decision $D_0$ (classify as factitious disorder):\n$$\nR(D_0 | x) = C(D_0, H_1) P(H_1 | x) + C(D_0, H_0) P(H_0 | x) = C_{FN} \\cdot P(H_1 | x) + 0 \\cdot P(H_0 | x) = C_{FN} P(H_1 | x)\n$$\nThe Bayes optimal decision rule is to choose the decision that minimizes this posterior expected loss. Therefore, we decide $D_1$ if $R(D_1 | x)  R(D_0 | x)$ and decide $D_0$ if $R(D_0 | x)  R(D_1 | x)$. The decision boundary, or threshold, occurs where the expected losses are equal, $R(D_1 | x) = R(D_0 | x)$.\n\nThe rule to decide $D_1$ is thus:\n$$\nC_{FP} P(H_0 | x)  C_{FN} P(H_1 | x)\n$$\nUsing Bayes' theorem, the posterior probability $P(H_j|x)$ can be expressed in terms of the class-conditional probability density function (likelihood) $p(x|H_j)$ and the prior probability $P(H_j) = \\pi_j$:\n$$\nP(H_j | x) = \\frac{p(x|H_j) \\pi_j}{p(x)}\n$$\nwhere $p(x) = \\sum_{j=0}^{1} p(x|H_j)\\pi_j$ is the marginal probability density of $x$. Substituting this into the inequality:\n$$\nC_{FP} \\frac{p(x|H_0) \\pi_0}{p(x)}  C_{FN} \\frac{p(x|H_1) \\pi_1}{p(x)}\n$$\nSince $p(x)$ is a density, it is non-negative, and for the regions of interest, it is strictly positive. We can multiply both sides by $p(x)$ and rearrange the terms to form a likelihood ratio test:\n$$\n\\frac{p(x|H_1)}{p(x|H_0)}  \\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\n$$\nThis inequality defines the decision rule: if the likelihood ratio $L(x) = p(x|H_1)/p(x|H_0)$ exceeds the threshold $\\lambda_{Bayes} = (C_{FP} \\pi_0) / (C_{FN} \\pi_1)$, we classify as $H_1$.\n\nThe problem states that the class-conditional densities are Gaussian with equal variance:\n$p(x|H_1) = \\mathcal{N}(\\mu_1, \\sigma^2) = \\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_1)^2}{2\\sigma^2}\\right)$\n$p(x|H_0) = \\mathcal{N}(\\mu_0, \\sigma^2) = \\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_0)^2}{2\\sigma^2}\\right)$\n\nThe likelihood ratio $L(x)$ is:\n$$\nL(x) = \\frac{\\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_1)^2}{2\\sigma^2}\\right)}{\\frac{1}{\\sqrt{2\\pi}\\sigma} \\exp\\left(-\\frac{(x - \\mu_0)^2}{2\\sigma^2}\\right)} = \\exp\\left(\\frac{(x - \\mu_0)^2 - (x - \\mu_1)^2}{2\\sigma^2}\\right)\n$$\nThe decision rule is to classify as $H_1$ if $L(x)  \\lambda_{Bayes}$. Since the natural logarithm is a strictly increasing function, we can take the logarithm of both sides without changing the inequality:\n$$\n\\ln(L(x))  \\ln(\\lambda_{Bayes})\n$$\n$$\n\\frac{(x - \\mu_0)^2 - (x - \\mu_1)^2}{2\\sigma^2}  \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nWe expand the quadratic terms in the numerator:\n$(x^2 - 2x\\mu_0 + \\mu_0^2) - (x^2 - 2x\\mu_1 + \\mu_1^2) = 2x(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)$.\nThe inequality becomes:\n$$\n\\frac{2x(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)}{2\\sigma^2}  \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nGiven $\\mu_1 = 60  \\mu_0 = 40$, the term $\\mu_1 - \\mu_0$ is positive. Thus, the left-hand side is an increasing function of $x$. The inequality is satisfied for $x$ greater than some threshold value. This is consistent with the decision rule format $X \\ge \\tau$. The optimal threshold $\\tau$ is the value of $x$ for which equality holds:\n$$\n\\frac{2\\tau(\\mu_1 - \\mu_0) - (\\mu_1^2 - \\mu_0^2)}{2\\sigma^2} = \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nSolving for $\\tau$:\n$2\\tau(\\mu_1 - \\mu_0) = (\\mu_1^2 - \\mu_0^2) + 2\\sigma^2 \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)$\n$\\tau = \\frac{\\mu_1^2 - \\mu_0^2}{2(\\mu_1 - \\mu_0)} + \\frac{2\\sigma^2}{2(\\mu_1 - \\mu_0)} \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)$\nUsing the identity $\\mu_1^2 - \\mu_0^2 = (\\mu_1 - \\mu_0)(\\mu_1 + \\mu_0)$:\n$$\n\\tau = \\frac{\\mu_1 + \\mu_0}{2} + \\frac{\\sigma^2}{\\mu_1 - \\mu_0} \\ln\\left(\\frac{C_{FP} \\pi_0}{C_{FN} \\pi_1}\\right)\n$$\nThis is the general expression for the optimal threshold $\\tau$ under the given conditions.\n\nNow, we substitute the numerical values provided in the problem:\n$\\mu_1 = 60$, $\\mu_0 = 40$, $\\sigma = 10$, $\\pi_1 = 0.65$, $\\pi_0 = 0.35$, $C_{FP} = 30$, $C_{FN} = 10$.\n\n$\\tau = \\frac{60 + 40}{2} + \\frac{10^2}{60 - 40} \\ln\\left(\\frac{30 \\times 0.35}{10 \\times 0.65}\\right)$\n$\\tau = \\frac{100}{2} + \\frac{100}{20} \\ln\\left(\\frac{10.5}{6.5}\\right)$\n$\\tau = 50 + 5 \\ln\\left(\\frac{21}{13}\\right)$\n\nTo obtain the numerical value, we compute the logarithm:\n$\\ln\\left(\\frac{21}{13}\\right) \\approx \\ln(1.6153846...) \\approx 0.4795604$\n$\\tau \\approx 50 + 5 \\times 0.4795604$\n$\\tau \\approx 50 + 2.397802$\n$\\tau \\approx 52.397802$\n\nThe problem requires rounding the result to four significant figures.\n$\\tau \\approx 52.40$\nThe optimal scalar threshold is $52.40$ on the score units of $X$.",
            "answer": "$$\n\\boxed{52.40}\n$$"
        }
    ]
}